Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 130.53 million as of April 4, 2025. Its market cap has decreased by -6.65% in one year.

Market Cap

130.53M

Enterprise Value

165.07M

Revenue

48.21M

Ranking

n/a

PE Ratio

8.20

Stock Price

6.69

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 130.53M, a decrease of -57.76%. That is a compound annual growth rate of -4.60%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	138.31M	-20.58%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	229.85B
Novartis AG	183.72B
Alcon	40.45B
Lonza Group AG	38.42B
Galderma Group AG	22.29B
Straumann Holding AG	16.84B
Sandoz Group AG	15.60B
Sonova Holding AG	15.02B

Market Cap Rankings